Document ID: chunk:federal_register_of_legislation:F2025C00119:front:0:p2
Version: federal_register_of_legislation:F2025C00119
Segment Type: other
Provision Reference: 
Character Range: 2838–5923

chemotherapy drug
15 Maximum quantity (number of units)—related pharmaceutical benefits
16 Maximum number of repeats—chemotherapy drugs
17 Maximum number of repeats—related pharmaceutical benefits
18 Variation of maximum amount or quantity or maximum number of repeats
19 Writing chemotherapy prescriptions that are not medication chart prescriptions
20 Writing medication chart prescriptions
21 Direction to vary prescribed dose of chemotherapy drug
Division 3—Supplying doses of chemotherapy drugs and related pharmaceutical benefits
22 Entitlement to receive special arrangement supplies
23 Special arrangement supplies of doses of chemotherapy drugs
24 Rules not applicable to special arrangement supplies of chemotherapy drugs
25 Modified rules for special arrangement supplies on the basis of an electronic medication chart prescription
Part 3—Claims, information and payment
Division 1—Claims for payment and giving information
26 Modified requirements for claims or giving information
Division 2—Payment of claims
27 Payment of approved pharmacists and approved medical practitioners for supplies of doses of chemotherapy drugs
28 Payment of approved hospital authorities for supplies
29 No separate entitlement to payment for supplies of diluent
30 Payment of TGA‑licensed compounders
Division 3—Dispensed price for dose of chemotherapy drug
31 Dispensed price for doses supplied by approved pharmacists and approved medical practitioners
32 Mark‑up for a chemotherapy pharmaceutical benefit
33 Dispensed price if dose is supplied by approved private hospital authority
34 Dispensed price if dose is supplied by approved public hospital authority
Division 4—Dispensed price for related pharmaceutical benefit
35 Dispensed price for supply of related pharmaceutical benefit
Part 4—Patient contributions
36 Supplies of doses of chemotherapy drugs by approved pharmacists and approved medical practitioners
37 Supplies of doses of chemotherapy drugs by approved hospital authorities
38 Supplies of related pharmaceutical benefits—special patient contribution
39 Application of safety net provisions
Part 5—Supply to CTG registered patients by CTG suppliers
40 Application of the CTG Special Arrangement—original special arrangement supply of a dose of a chemotherapy drug
41 Application of the CTG Special Arrangement—special arrangement supply of a related pharmaceutical benefit
Schedule 1—Chemotherapy pharmaceutical benefits and chemotherapy drugs
Part 1—Chemotherapy pharmaceutical benefits
1 Chemotherapy pharmaceutical drugs and chemotherapy pharmaceutical benefits
Part 2—Maximum amounts and number of repeats for chemotherapy drugs
2 Maximum amounts and number of repeats
Schedule 2—Related pharmaceutical benefits
1 Related pharmaceutical benefits and related information
Schedule 3—Circumstances, purposes and variations
Part 1—Circumstances and purposes
1 Circumstances and purposes
Part 2—Variation rules
2 Variation rules
Endnotes
Endnote 1—About the endnotes
Endnote 2—Abbreviation key
Endnote 3—Legislation history
Endnote 4—Amendment history

Part 1—Preliminary